Vivek Garipalli

This profile gathers the share dealings of Vivek Garipalli in Clover Health Investments, CORP. /de, where the filings describe the role as senior executive. We count 8 filings; the first trade dates from 7 January 2022 and the latest from 7 January 2026.

On the market, this insider has only ever bought: 3 purchases, €2.6M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 option exercises.

The median purchase comes to €916k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +29.5%. Past outcomes like these are no guarantee of what comes next.

On 9 January 2026 came the latest disclosure, an option exercise in Clover Health Investments, CORP. /de. The latest purchase dates back some time: it was published 442 days ago, on 8 August 2025. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.